Boston Business Journal: Serial entrepreneur, former IFM CEO launches immuno-oncology startup

Rowan Walrath

It wasn’t long ago that serial biotech entrepreneur Gary Glick said he was settling down. Glick, the former CEO of IFM Therapeutics, had launched precision-medicine startup Scorpion Therapeutics in 2020 when he told the Business Journal: “It will be the last company that I start.”

Read more